Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

New Agents for the Treatment of Advanced Bladder Cancer.

Cheetham PJ, Petrylak DP.

Oncology (Williston Park). 2016 Jun;30(6):571-9, 588. Review.

2.

Role of complimentary therapy for male LUTS.

Cheetham PJ.

Curr Urol Rep. 2013 Dec;14(6):606-13. doi: 10.1007/s11934-013-0372-3.

PMID:
24026362
3.

Tubulin-targeted agents including docetaxel and cabazitaxel.

Cheetham P, Petrylak DP.

Cancer J. 2013 Jan-Feb;19(1):59-65. doi: 10.1097/PPO.0b013e3182828d38. Review.

PMID:
23337758
4.
5.

Comparison of biochemical failure definitions for predicting local cancer recurrence following cryoablation of the prostate.

Pitman M, Shapiro EY, Hruby GW, Truesdale MD, Cheetham PJ, Saad S, Katz AE.

Prostate. 2012 Dec 1;72(16):1802-8. doi: 10.1002/pros.22541. Epub 2012 May 22.

PMID:
22618738
6.

Words of wisdom. Re: Abiraterone and increased survival in metastatic prostate cancer.

Cheetham PJ, Petrylak DP.

Eur Urol. 2012 Apr;61(4):850. doi: 10.1016/j.eururo.2012.01.036. No abstract available.

PMID:
22373884
7.

Testosterone in prostate cancer: the Bethesda consensus.

Djavan B, Eastham J, Gomella L, Tombal B, Taneja S, Dianat SS, Kazzazi A, Shore N, Abrahamsson PA, Cheetham P, Moul J, Lepor H, Crawford ED.

BJU Int. 2012 Aug;110(3):344-52. doi: 10.1111/j.1464-410X.2011.10719.x. Epub 2011 Nov 30. Review.

8.

Diet and prostate cancer - a holistic approach to management.

Cheetham PJ, Katz AE.

Arch Esp Urol. 2011 Oct;64(8):720-34. Review. English, Spanish.

PMID:
22052755
9.

Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings.

Croxall G, Hale J, Weston V, Manning G, Cheetham P, Achtman M, McNally A.

J Antimicrob Chemother. 2011 Nov;66(11):2501-8. doi: 10.1093/jac/dkr349. Epub 2011 Aug 22.

PMID:
21862477
10.

Vitamin D deficiency in the urological population: a single center analysis.

Pitman MS, Cheetham PJ, Hruby GW, Katz AE.

J Urol. 2011 Oct;186(4):1395-9. doi: 10.1016/j.juro.2011.05.072.

PMID:
21855943
11.

Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples.

Croxall G, Weston V, Joseph S, Manning G, Cheetham P, McNally A.

J Med Microbiol. 2011 Jan;60(Pt 1):102-9. doi: 10.1099/jmm.0.020602-0. Epub 2010 Oct 14.

PMID:
20947667
12.

An evaluation of patient selection criteria on predicting progression-free survival after primary focal unilateral nerve-sparing cryoablation for prostate cancer: recommendations for follow up.

Truesdale MD, Cheetham PJ, Hruby GW, Wenske S, Conforto AK, Cooper AB, Katz AE.

Cancer J. 2010 Sep-Oct;16(5):544-9. doi: 10.1097/PPO.0b013e3181f84639.

PMID:
20890154
13.

Gleason score concordance on biopsy-confirmed prostate cancer: is pathological re-evaluation necessary prior to radical prostatectomy?

Truesdale MD, Cheetham PJ, Turk AT, Sartori S, Hruby GW, Dinneen EP, Benson MC, Badani KK.

BJU Int. 2011 Mar;107(5):749-754. doi: 10.1111/j.1464-410X.2010.09570.x. Epub 2010 Sep 14.

14.

Does the presence of robotic surgery affect demographics in patients choosing to undergo radical prostatectomy? A multi-center contemporary analysis.

Cheetham PJ, Lee DJ, Rose-Morris A, Brewster SF, Badani KK.

J Robot Surg. 2010 Sep;4(3):155-60. doi: 10.1007/s11701-010-0200-4. Epub 2010 Jul 10.

PMID:
27638755
15.

Use of a flexible carbon dioxide laser fiber for precise dissection of the neurovascular bundle during robot-assisted laparoscopic prostatectomy.

Cheetham PJ, Truesdale MD, Lee DJ, Landman JM, Badani KK.

J Endourol. 2010 Jul;24(7):1091-6. doi: 10.1089/end.2010.0132.

PMID:
20575698
16.
17.

Long-term cancer-specific and overall survival for men followed more than 10 years after primary and salvage cryoablation of the prostate.

Cheetham P, Truesdale M, Chaudhury S, Wenske S, Hruby GW, Katz A.

J Endourol. 2010 Jul;24(7):1123-9. doi: 10.1089/end.2010.0130.

PMID:
20575687
18.

Predictors of early urinary continence after robotic prostatectomy.

Lee DJ, Cheetham P, Badani KK.

Can J Urol. 2010 Jun;17(3):5200-5.

PMID:
20566014
19.
20.

A management algorithm for hematospermia.

Aslam MI, Cheetham P, Miller MA.

Nat Rev Urol. 2009 Jul;6(7):398-402. doi: 10.1038/nrurol.2009.98. Review.

PMID:
19578357
21.

Genotypic and phenotypic analysis of Enterobacter sakazakii strains from an outbreak resulting in fatalities in a neonatal intensive care unit in France.

Caubilla-Barron J, Hurrell E, Townsend S, Cheetham P, Loc-Carrillo C, Fayet O, Prère MF, Forsythe SJ.

J Clin Microbiol. 2007 Dec;45(12):3979-85. Epub 2007 Oct 10.

22.

Bioprocesses for the manufacture of ingredients for foods and cosmetics.

Cheetham PS.

Adv Biochem Eng Biotechnol. 2004;86:83-158. Review.

PMID:
15088764
23.

Attitudes and use of alternative therapies in UK prostate cancer patients-isn't it time we were in the know?

Cheetham PJ, Le Monnier KJ, Brewster SF.

Prostate Cancer Prostatic Dis. 2001;4(4):235-241.

24.
25.
26.

A 23-year review of the management of acute retention of urine: progressing or regressing?

Modi P, Pleat J, Cheetham P, Senior J, Johan R, Fellows GJ.

Ann R Coll Surg Engl. 2000 Sep;82(5):333-5.

27.

A comparison of two motion analysis systems for the measurement of two-dimensional rearfoot motion during walking.

Mannon K, Anderson T, Cheetham P, Cornwall MW, McPoil TG.

Foot Ankle Int. 1997 Jul;18(7):427-31.

PMID:
9252813
28.

Biocatalytic synthesis of disaccharide high-intensity sweeterner sucralose via a tetrachlororaffinose intermediate.

Bennett C, Dordick JS, Hacking AJ, Cheetham PS.

Biotechnol Bioeng. 1992 Jan 20;39(2):211-7.

PMID:
18600933
29.

Biological method for protection of 6-position of sucrose and its use in synthesis of disaccharide high-intensity sweetener.

Jones JD, Hacking AJ, Cheetham PS.

Biotechnol Bioeng. 1992 Jan 20;39(2):203-10.

PMID:
18600932
30.

Voluntary review of obstetric and gynecologic services.

Gibbs CE, Cheetham PS.

QRB Qual Rev Bull. 1988 Sep;14(9):290-3. No abstract available.

PMID:
3148881
31.

Dermatophyte fungi: improved isolation in a hospital laboratory.

Cheetham P, Holland SJ.

Med Lab Sci. 1988 Apr;45(2):139-42. No abstract available.

PMID:
3210919
32.

Urinary tract infection with anaerobic bacteria following endoscopic urethral instrumentation.

Sutton R, Cheetham P, Bullock DW, Munson KW.

Br J Urol. 1987 Apr;59(4):353-7.

PMID:
3580776
33.
34.

The use of a hydrophobic resin as a product reservoir in steroid transformations.

Saunders RP, Hardman R, Cheetham PS.

Biotechnol Bioeng. 1985 Jun;27(6):825-31.

PMID:
18553742
35.
36.
38.

Removal of triton X-100 from aqueous solution using amberlite XAD-2.

Cheetham PS.

Anal Biochem. 1979 Jan 15;92(2):447-52. No abstract available.

PMID:
443545
39.

A benign deficiency of typeB beta-galactosidase in human liver.

Cheetham PS, Dance NE, Robinson D.

Clin Chim Acta. 1978 Feb 1;83(1-2):67-74.

PMID:
23231
40.
41.

Isoenzymes of human liver beta-galactosidase.

Cheetham PS, Dance N, Robinson D.

Biochem Soc Trans. 1975;3(2):240-1. No abstract available.

PMID:
236941
42.

Hydrolysis of GM1-ganglioside by human liver beta-galactosidase isoenzymes.

Ho MW, Cheetham P, Robinson D.

Biochem J. 1973 Oct;136(2):351-9.

Supplemental Content

Loading ...
Support Center